Clinical trial · Observational
Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
NCT07100444CI-TRIAL-00093053completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to compare the clinical features and postoperative survival outcomes between patients with spinal metastasis as the initial manifestation of malignancy and those with spinal metastasis occurring after an established diagnosis of malignancy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Metastasis | Lung Neoplasm | PROBABILISTIC | 0.70 |
| Lung Cancers | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Spinal Metastasis as the First Presentation of Lung Malignancy
- description
- It refers to patients who first present with symptoms such as pain or spinal cord compression caused by spinal metastasis, leading to the initial detection of bone metastasis, and are subsequently diagnosed with lung cancer.
- label
- lung cancer who subsequently developed spinal metastasis
- description
- It refers to patients with a history of treatment for primary lung cancer who subsequently developed spinal metastasis during the course of the disease.
Primary outcomes (1)
- measure
- Postoperative Overall Survival
- timeFrame
- From the date of surgery until death or last follow-up, up to 5 years
- description
- Postoperative overall survival is defined as the time from the date of surgery for spinal metastasis to the date of death from any cause. Patients who are still alive at the last follow-up will be censored at that date. Survival status will be ascertained by clinical follow-up and/or review of medical records.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age ≥ 18 years. 2. Pathologically or radiologically confirmed diagnosis of lung cancer with spinal metastasis. 3. Patients with spinal metastasis who underwent surgical intervention. 4. Adequate medical records and follow-up data available. Exclusion Criteria: 1. Patients with spinal metastasis originating from non-lung primary tumors. 2. Patients who did not receive surgical treatment for spinal metastasis. 3. Incomplete clinical data or lost to follow-up.
References
Publications (0)
Data not yet available
No reference posted for this study.